Benign prostatic hyperplasia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients aged 50–80 years undergoing transurethral resection of the prostate; 2. Requiring continuous bladder irrigation for >=24 hours postoperatively; 3. Development of at least one bladder irrigation-related complication within 48 hours postoperatively; 4. Voluntary participation in the study with signed written informed consent; 5. Preoperative International Prostate Symptom Score (IPSS) >=8 points without concomitant severe bladder dysfunction.
Exclusion criteria
Exclusion criteria: 1. Patients with concurrent urinary tract infections; 2. Patients with a history of neurogenic bladder; 3. Patients with concurrent neurological disorders; 4. Patients with concurrent malignant tumors; 5. Patients with severe cardiopulmonary insufficiency; 6. History of pelvic surgery or lower urinary tract trauma; 7. Patients with cognitive impairment, hemiplegia, or lower limb sensory deficits who cannot cooperate with the study; 8. Patients with skin allergies; 9. Participants who have enrolled in other clinical trials or demonstrate poor compliance.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence and Severity of Bladder Spasms;Infection Status;Bleeding condition; | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum/urine inflammatory cytokines, including IL-6 and TNF-a;Neurotransmitters, including substance P and ß-endorphin;Pathological biopsy of the bladder mucosa; | — |
Countries
China
Contacts
Shanghai University of Traditional Chinese Medicine Affiliated Shuguang Hospital Yunnan Qujing Hospital